ANDAORALTABLET
Approved
Dec 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
drug. [see Microbiology ()]
Indications (7)
development of drug-resistant bacteriamaintain the effectiveness of azithromycin for oral suspensionother antibacterial drugsazithromycin for oral suspension should be used only to treat infectionsstrongly suspected to be caused by susceptible bacteriamaintain the effectiveness of azithromycinazithromycin should be used only to treat infections
Clinical Trials (5)
Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations
Started Mar 2024
1,311 enrolled
Chronic Obstructive Pulmonary Disease
Azithromycin Before Induction
Started Aug 2023
400 enrolled
Infections
A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications
Started Nov 2021
12 enrolled
Chronic Obstructive Pulmonary Disease
The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)
Started May 2021
2,150 enrolled
Typhoid Fever
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
Started Feb 2021